A global study of zoliflodacin, a drug candidate for gonorrhea, found "unprecedented" phase 3 results, its drugmaker said Nov. 1. 

In August, CVS said it would cut about 5,000 jobs, and a few weeks later, its workforce was notified of layoffs in at least nine states. Before Halloween, the retail chain filed more WARN notices. 

The FDA is advising healthcare workers who administer Moderna's COVID-19 pediatric vaccine to only administer 0.25 milliliters instead of the entire vial. 

As the three-day walkouts among CVS, Walgreens and Rite Aid pharmacy employees come to a close, hospital pharmacy leaders shared with Becker's their workforce concerns. 

There's been no way to confirm how many pharmacists and pharmacy technicians have participated at planned walkouts at CVS, Rite Aid and Walgreens locations nationwide, though estimates and reports suggest a quiet turnout. 

Compared to 2022, there is a 15% higher demand for hospital pharmacists so far in 2023, according to a recent report from the American Association of Colleges of Pharmacy. 

Pfizer is shuttering its location in Gladstone, N.J., and the company is offering to relocate the current employees.

Cleveland Clinic is the latest health system to invest in drones that deliver prescription medications to patients' homes. 

Organizers estimate as many as 4,500 pharmacists and pharmacy technicians at CVS, Rite Aid and Walgreens are participating in a three-day walkout that began Oct. 30.

Michael Hogue, PharmD, CEO and executive vice president of the American Pharmacists Association, has issued a statement of support for the planned walkouts by Walgreens and CVS pharmacy employees that began Oct. 30. 

The FDA label for Ozempic does not mention muscle pain, but some patients taking the popular Type 2 diabetes drug for weight loss are experiencing the side effect, according to an Oct. 27 report in women's magazine First for Women.

A panel of FDA advisers concluded after hours of discussion Oct. 31 that the first CRISPR gene therapy candidate is safe enough for clinical use, The New York Times reported. 

'Pharmageddon' is the nickname for a planned walkout by pharmacists at U.S. drugstore chains set to begin Oct. 30, although there is no count for how many workers will participate.

Drugmaker Eli Lilly announced Oct. 26 that Omvoh, its ulcerative colitis medication, has received approval from the FDA. 

Sanofi said it plans to separate from its consumer healthcare business — a move the company says will allow it to focus more on creating "transformative medicine and vaccines." 

After the FDA told hospitals to not give preterm infants probiotics following one baby's death, the agency sent warning letters to Abbott Laboratories and Infinant Health. 

The FDA declared the shortage resolved for Pluvicto, a prostate cancer drug made by Novartis.

Hospitals and health systems across the nation are among thousands of healthcare facilities participating in the Drug Enforcement Agency's National Prescription Drug Take Back Day on Oct. 28. 

A combined phase 1 and 2 clinical trial of Pfizer's mRNA flu and COVID-19 combination vaccine have yielded positive results, the company announced Oct. 26.

A growing pile of research is finding a positive correlation between vaccinations and a reduced risk of Alzheimer's disease and related dementias, The Washington Post reported Oct. 26.